NovoCure Ltd - Common Stock (NVCR)

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Common Stock
Shares outstanding
111,111,111
Total 13F shares
18,826,170
Share change
-1,553,188
Total reported value
$160,713,151
Put/Call ratio
16%
Price per share
$8.54
Number of holders
62
Value change
-$21,836,369
Number of buys
33
Number of sells
22

Institutional Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2016

As of 30 Sep 2016, NovoCure Ltd - Common Stock (NVCR) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,826,170 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, HIGHLINE CAPITAL MANAGEMENT, L.P., StepStone Group LP, BlackRock Fund Advisors, PEREGRINE CAPITAL MANAGEMENT LLC, STATE STREET CORP, Tamarack Advisers, LP, COURAGE CAPITAL MANAGEMENT LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 62 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.